An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)
Clinical trial NCT01224093 · COMPLETED
Trial details
- NCT number
- NCT01224093
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-02-01
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.